ID

22049

Description

Study part: Prior treatment for breast cancer (Adjuvant setting). A phase III multinational, randomized, single-blind study of recombinant humanized anti-p185HER2 monoclonal antibody (rhuMAb HER2) in patients with HER2/neu overexpression who have not received prior cytotoxic chemotherapy for metastatic breast cancer. "Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche"

Keywords

Versions (2)
  1. 5/16/17 5/16/17 -
  2. 3/15/21 3/15/21 - Dr. rer. medic Philipp Neuhaus
Copyright Holder

Roche

Uploaded on

May 16, 2017

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

PRIOR TREATMENT FOR BREAST CANCER (ADJUVANT SETTING) Roche H0650g Breast Cancer

English

PRIOR TREATMENT FOR BREAST CANCER (ADJUVANT SETTING)

1 forms  
REGIMEN 1
Description

REGIMEN 1

Alias
UMLS CUI-1
C0392920
PATIENT INT.
Description

Patient initial

Data type

text

Alias
UMLS CUI [1]
C2986440
PATIENT NUMBER
Description

Patient id

Data type

integer

Alias
UMLS CUI [1]
C2348585
CHEMOTHERAPY?
Description

Chemotherapy

Data type

boolean

Alias
UMLS CUI [1]
C0392920
START DATE OF FIRST AGENT
Description

therapy start date

Data type

date

Alias
UMLS CUI [1]
C1531783
STOP DATE OF LAST AGENT
Description

therapy stop date

Data type

date

Alias
UMLS CUI [1]
C1531784
AGENT(S)
Description

Pharmaceutical Preparations

Data type

text

Alias
UMLS CUI [1]
C0013227
CUMULATIVE DOSE RC'D (Units)
Description

CUMULATIVE DOSE

Data type

text

Alias
UMLS CUI [1]
C2986497
NUMBER OF CYCLES
Description

NUMBER OF CYCLES

Data type

integer

Alias
UMLS CUI [1,1]
C0449788
UMLS CUI [1,2]
C1302181
REGIMEN 2
Description

REGIMEN 2

Alias
UMLS CUI-1
C1276413
START DATE OF FIRST AGENT
Description

therapy start date

Data type

date

Alias
UMLS CUI [1]
C1531783
STOP DATE OF LAST AGENT
Description

therapy stop date

Data type

date

Alias
UMLS CUI [1]
C1531784
AGENT(S)
Description

Pharmaceutical Preparations

Data type

text

Alias
UMLS CUI [1]
C0013227
CUMULATIVE DOSE RC'D (Units)
Description

CUMULATIVE DOSE

Data type

text

Alias
UMLS CUI [1]
C2986497
NUMBER OF CYCLES
Description

NUMBER OF CYCLES

Data type

integer

Alias
UMLS CUI [1,1]
C0449788
UMLS CUI [1,2]
C1302181
ADJUVANT THERAPY
Description

ADJUVANT THERAPY

Alias
UMLS CUI-1
C0677850
WAS A HIGH-DOSE CONSOLIDATION THERAPY GIVEN?
Description

CONSOLIDATION THERAPY

Data type

boolean

Alias
UMLS CUI [1]
C1511484
DID THE PATIENT RECEIVE A BONE MARROW OR STEM CELL- TRANSPLANT?
Description

Bone marrow transplantation; stem cell transplantation

Data type

boolean

Alias
UMLS CUI [1]
C1504389
DID PATIENT PROGRESS WITHIN 12 MONTHS FOLLOWING THE ADJUVANT CHEMOTHERAPY?
Description

Disease progression

Data type

boolean

Alias
UMLS CUI [1]
C0242656
WHAT WAS THE TOTAL DOSE OF DOXORUBICIN IN AN ADJUVANT SETTING?
Description

Total dose Doxorubicin

Data type

float

Measurement units
  • mg/m^2
Alias
UMLS CUI [1,1]
C2986497
UMLS CUI [1,2]
C0013089
UMLS CUI [1,3]
C0014582
mg/m^2
WHAT WAS THE TOTAL DOSE OF EPIRUBICIN USED IN AN ADJUVANT SETTING?
Description

Total dose Epirubicin

Data type

float

Measurement units
  • mg/m^2
Alias
UMLS CUI [1,1]
C2986497
UMLS CUI [1,2]
C0014582
mg/m^2
Back to the top of the page

Similar models

PRIOR TREATMENT FOR BREAST CANCER (ADJUVANT SETTING)

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
REGIMEN 1
C0392920 (UMLS CUI-1)
Patient initial
Item
PATIENT INT.
text
C2986440 (UMLS CUI [1])
Patient id
Item
PATIENT NUMBER
integer
C2348585 (UMLS CUI [1])
Chemotherapy
Item
CHEMOTHERAPY?
boolean
C0392920 (UMLS CUI [1])
therapy start date
Item
START DATE OF FIRST AGENT
date
C1531783 (UMLS CUI [1])
therapy stop date
Item
STOP DATE OF LAST AGENT
date
C1531784 (UMLS CUI [1])
Pharmaceutical Preparations
Item
AGENT(S)
text
C0013227 (UMLS CUI [1])
CUMULATIVE DOSE
Item
CUMULATIVE DOSE RC'D (Units)
text
C2986497 (UMLS CUI [1])
NUMBER OF CYCLES
Item
NUMBER OF CYCLES
integer
C0449788 (UMLS CUI [1,1])
C1302181 (UMLS CUI [1,2])
Item Group
REGIMEN 2
C1276413 (UMLS CUI-1)
therapy start date
Item
START DATE OF FIRST AGENT
date
C1531783 (UMLS CUI [1])
therapy stop date
Item
STOP DATE OF LAST AGENT
date
C1531784 (UMLS CUI [1])
Pharmaceutical Preparations
Item
AGENT(S)
text
C0013227 (UMLS CUI [1])
CUMULATIVE DOSE
Item
CUMULATIVE DOSE RC'D (Units)
text
C2986497 (UMLS CUI [1])
NUMBER OF CYCLES
Item
NUMBER OF CYCLES
integer
C0449788 (UMLS CUI [1,1])
C1302181 (UMLS CUI [1,2])
Item Group
ADJUVANT THERAPY
C0677850 (UMLS CUI-1)
CONSOLIDATION THERAPY
Item
WAS A HIGH-DOSE CONSOLIDATION THERAPY GIVEN?
boolean
C1511484 (UMLS CUI [1])
Bone marrow transplantation; stem cell transplantation
Item
DID THE PATIENT RECEIVE A BONE MARROW OR STEM CELL- TRANSPLANT?
boolean
C1504389 (UMLS CUI [1])
Disease progression
Item
DID PATIENT PROGRESS WITHIN 12 MONTHS FOLLOWING THE ADJUVANT CHEMOTHERAPY?
boolean
C0242656 (UMLS CUI [1])
Total dose Doxorubicin
Item
WHAT WAS THE TOTAL DOSE OF DOXORUBICIN IN AN ADJUVANT SETTING?
float
C2986497 (UMLS CUI [1,1])
C0013089 (UMLS CUI [1,2])
C0014582 (UMLS CUI [1,3])
Total dose Epirubicin
Item
WHAT WAS THE TOTAL DOSE OF EPIRUBICIN USED IN AN ADJUVANT SETTING?
float
C2986497 (UMLS CUI [1,1])
C0014582 (UMLS CUI [1,2])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial